| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
PT Kedoya Adyaraya Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp990.00 |
| 52 Week High | Rp1,550.00 |
| 52 Week Low | Rp980.00 |
| Beta | 0.075 |
| 1 Month Change | -10.00% |
| 3 Month Change | -17.84% |
| 1 Year Change | -7.48% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -53.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| RSGK | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | -0.5% | -3.4% | -4.7% |
| 1Y | -7.5% | 2.2% | 3.5% |
Return vs Industry: RSGK underperformed the ID Healthcare industry which returned 2.2% over the past year.
Return vs Market: RSGK underperformed the ID Market which returned 3.5% over the past year.
Price Volatility
| RSGK volatility | |
|---|---|
| RSGK Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in ID Market | 12.6% |
| 10% least volatile stocks in ID Market | 2.6% |
Stable Share Price: RSGK has not had significant price volatility in the past 3 months.
Volatility Over Time: RSGK's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 721 | Liem Hong | www.grhahospitals.com |
PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. The company provides facilities, such as inpatient and outpatient room, operating room, delivery room, HCU, ICU, ICCU, PICU, NICU, emergency room, inpatient, outpatient, covid ICU isolation, endoscopy, operating room, sterilization service center installation, and delivery room. It also offers medical support services, including pharmacy, radiology, CT-Scan, mammography, mobile x-ray, general x-ray, 4D ultrasound, central sterile supply department, fluoroscopy unit, mobile C-Arm, bone densitometry, laparoscopy, bronchoscopy, catheterization laboratory, spirometry, audiometry, electroencephalography, electromyography, electrocardiogram, treadmill, echocardiography, hemodialysis, laser treatment, medical rehabilitation, trauma center, nutrition unit, medical record, panoramic, cephalometry, digital radiography, 4D USG, and 2D/3D USG, as well as laboratories for chemistry, hematology, hemostasis, microbiology, immune-serology, and biomolecular.
PT Kedoya Adyaraya Tbk Fundamentals Summary
| RSGK fundamental statistics | |
|---|---|
| Market cap | Rp920.38b |
| Earnings (TTM) | Rp32.74b |
| Revenue (TTM) | Rp399.43b |
28.1x
P/E Ratio2.3x
P/S RatioIs RSGK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RSGK income statement (TTM) | |
|---|---|
| Revenue | Rp399.43b |
| Cost of Revenue | Rp257.13b |
| Gross Profit | Rp142.30b |
| Other Expenses | Rp109.56b |
| Earnings | Rp32.74b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 35.22 |
| Gross Margin | 35.63% |
| Net Profit Margin | 8.20% |
| Debt/Equity Ratio | 0% |
How did RSGK perform over the long term?
See historical performance and comparison